Produktname:5-Bromo-2-(trifluoromethoxy)aniline
IUPAC Name:5-bromo-2-(trifluoromethoxy)aniline
- CAS:886762-08-9
- Molekulare Formel:C7H5BrF3NO
- Reinheit:98%
- Katalognummer:CM118425
- Molekulargewicht:256.02
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:886762-08-9
- Molekulare Formel:C7H5BrF3NO
- Schmelzpunkt:-
- SMILES-Code:NC1=CC(Br)=CC=C1OC(F)(F)F
- Dichte:
- Katalognummer:CM118425
- Molekulargewicht:256.02
- Siedepunkt:230.2°C at 760 mmHg
- Mdl-Nr.:MFCD04039242
- Lagerung:Keep in dark place, store at 2-8°C.
Column Infos
- Onvansertib
- Polo-like kinase 1 (PLK1) is a key regulator of the cell-cycle progression found in human cancers, and a potential therapeutic target for oncology drug development. The recent journal Clinical Cancer Research details the Phase 1b Study of Onvansertib in combination with chemotherapy+bevacizumab treatment for patients with patients with KRAS-mutated metastatic colorectal cancer (mCRC).
Cardiff Oncology’s novel inhibitor, Onvansertib effectively targets PLK1, that prevents from tumor cell growth. It aids restore DNA damage and promote the efficacy of the standard of care therapy in a number of indications.